Live Breaking News & Updates on Gsk

Stay informed with the latest breaking news from Gsk on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Gsk and stay connected to the pulse of your community

GSK (LON:GSK) PT Raised to GBX 1,820

GSK (LON:GSK – Get Free Report) had its price objective lifted by investment analysts at Berenberg Bank from GBX 1,650 ($20.84) to GBX 1,820 ($22.99) in a report released on Wednesday, Marketbeat Ratings reports. The firm currently has a “buy” rating on the stock. Berenberg Bank’s price objective indicates a potential upside of 9.44% from […]

United-states , United-kingdom , Urs-rohner , Julie-brown , Berenberg-bank , Company-profile , Barclays , Citigroup , Get-free-report , Marketbeat-ratings , Shore-capital , Gsk

GSK plc (NYSE:GSK) Short Interest Up 18.3% in January

GSK plc (NYSE:GSK – Get Free Report) saw a significant growth in short interest during the month of January. As of January 31st, there was short interest totalling 3,290,000 shares, a growth of 18.3% from the January 15th total of 2,780,000 shares. Based on an average daily volume of 3,270,000 shares, the days-to-cover ratio is […]

United-kingdom , United-states , Fairfield-bush , Morgan-stanley , Citigroup , Jpmorgan-chase-co , Jefferies-financial-group , Company-profile , Panagora-asset-management-inc , Blair-william-co , Get-free-report

GSK plc (NYSE:GSK) Shares Purchased by Causeway Capital Management LLC

Causeway Capital Management LLC lifted its holdings in shares of GSK plc (NYSE:GSK – Free Report) by 41.4% in the 3rd quarter, according to its most recent Form 13F filing with the SEC. The firm owned 564,747 shares of the pharmaceutical company’s stock after buying an additional 165,317 shares during the period. Causeway Capital Management […]

Canada , United-kingdom , United-states , Arrowstreet-capital-limited-partnership , Company-profile , Provident-trust-co , Causeway-capital-management , Jefferies-financial-group , Goldman-sachs-group-inc , Citigroup , Morgan-stanley

Tocqueville Asset Management L.P. Acquires 23,700 Shares of GSK plc (NYSE:GSK)

Tocqueville Asset Management L.P. increased its holdings in shares of GSK plc (NYSE:GSK – Free Report) by 87.5% during the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 50,800 shares of the pharmaceutical company’s stock after acquiring an additional 23,700 shares […]

Indiana , United-states , United-kingdom , Larson-financial-group , Citigroup , Nelson-van-denburg-campbell-wealth-management-group , Indiana-trust-investment-management , Fairfield-bush , Capital-advisors-inc , Exchange-commission , Jefferies-financial-group

Discontinued asthma drug stirs frustrations

Discontinued asthma drug stirs frustrations
beckershospitalreview.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from beckershospitalreview.com Daily Mail and Mail on Sunday newspapers.

Cnn , Gsk , Iscontinued , Rand-name , Sthma-drug , Lovent , Eneric-solution , Rugmaker , Luticasone , Ayers , Lternative-therapies

Some Pregnant Women and Infants Received the Wrong R.S.V. Shots

Doctors and pharmacists seem to be confused by the guidelines. And the brand names aren’t helping.

Sarah-long , Pfizer , Centers-for-disease , Disease-control , Vaccines-immunization , Children , Babies , Clinical-trial , Rsv , Premature-baby , Pregnancy , Drugstore

Waters Parkerson & CO. LLC Has $672,000 Position in GSK plc (NYSE:GSK)

Waters Parkerson & CO. LLC raised its holdings in GSK plc (NYSE:GSK – Free Report) by 3.1% in the 3rd quarter, according to the company in its most recent filing with the SEC. The firm owned 18,530 shares of the pharmaceutical company’s stock after acquiring an additional 550 shares during the quarter. Waters Parkerson & […]

Indiana , United-states , United-kingdom , Fairfield-bush , Jefferies-financial-group , Capital-advisors-inc , Nelson-van-denburg-campbell-wealth-management-group , Indiana-trust-investment-management , Larson-financial-group , Citigroup , Company-profile

Waters Parkerson & CO. LLC Grows Stock Position in GSK plc (NYSE:GSK)

Waters Parkerson & CO. LLC grew its holdings in GSK plc (NYSE:GSK – Free Report) by 3.1% during the third quarter, HoldingsChannel.com reports. The firm owned 18,530 shares of the pharmaceutical company’s stock after acquiring an additional 550 shares during the quarter. Waters Parkerson & CO. LLC’s holdings in GSK were worth $672,000 at the […]

United-states , United-kingdom , Fintrust-capital-advisors , Waters-parkerson , Jefferies-financial-group , Morgan-stanley , Prospera-financial-services-inc , Citigroup , Free-report , Trust-capital-advisors , Financial-services-inc

Global stocks slip as US inflation data spooks investors

Euronext Dublin finished the day down 0.3% as it was dragged lower by homebuilders and hotels group Dalata

Philadelphia , Pennsylvania , United-states , Germany , Dublin , Ireland , London , City-of , United-kingdom , Smurfit-kappa , Richard-ball , Taylor-wimpey

GSK (LON:GSK) Receives "Buy" Rating from Barclays

Barclays reiterated their buy rating on shares of GSK (LON:GSK – Free Report) in a report published on Friday morning, Marketbeat.com reports. Barclays currently has a GBX 1,950 ($24.45) target price on the stock. A number of other research firms also recently issued reports on GSK. Berenberg Bank reiterated a buy rating and set a […]

United-kingdom , United-states , Urs-rohner , Julie-brown , Citigroup , Barclays , Berenberg-bank , Free-report , Shore-capital , Get-free-report , Gsk , Lon-gsk